Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters

Database
Language
Publication year range
1.
Biomed Res Int ; 2023: 9911397, 2023.
Article in English | MEDLINE | ID: mdl-37564141

ABSTRACT

The anti-dementia effect following ischemic stroke with metabolic syndrome (MetS) of the polyherbal functional ingredient comprising ginger, Chinese date, and wood ear mushroom (GCJ) was hypothesized due to its neuroprotective effect against stroke. This study was performed to test this hypothesis and to explore the underlying mechanism. Male Wistar rats weighing 180-220 g were induced metabolic syndrome (MetS) with a 16-week high-carbohydrate high-fat diet (HCHF) feeding. The rats with MetS characteristics were orally administered GCJ at various doses (GCJ100, GCJ200, and GCJ300 mg kg-1 BW) 21 days pre-induction and 21 days post-induction of reperfusion injury (I/R) at the right middle cerebral artery (MCAO). Memory was evaluated every 7 days during the study period. At the end of the study, neuron density, AChE activity, and the expressions of eNOS, BDNF, and pERK/ERK in the prefrontal cortex, and hippocampus were also determined. MetS rats with GCJ treatment improved memory impairment, enhanced neuron density, and increased the expressions of eNOS, BDNF, and pERK/ERK but suppressed AChE in both areas. Therefore, the anti-dementia effect following ischemic stroke with metabolic syndrome of GCJ may involve the improvement of AChE, eNOS, BDNF, pERK/ERK, and neural plasticity. However, this required confirmation by clinical study.


Subject(s)
Dementia , Drugs, Chinese Herbal , Ischemic Stroke , Metabolic Syndrome , Neuroprotective Agents , Animals , Male , Rats , Agaricales , Brain-Derived Neurotrophic Factor , Cerebral Cortex/drug effects , Cerebral Cortex/metabolism , Dementia/drug therapy , Dementia/etiology , Dementia/genetics , Drugs, Chinese Herbal/pharmacology , Drugs, Chinese Herbal/therapeutic use , Zingiber officinale , Ischemic Stroke/complications , Ischemic Stroke/drug therapy , Metabolic Syndrome/drug therapy , Metabolic Syndrome/genetics , Metabolic Syndrome/metabolism , Neuroprotective Agents/pharmacology , Neuroprotective Agents/therapeutic use , Phoeniceae , Rats, Wistar , Disease Models, Animal
SELECTION OF CITATIONS
SEARCH DETAIL